Closed Tip Dynamic Microvalve Protection Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/970,202, filed Mar 25, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,502,479 | Closed Tip Dynamic Microvalve Protection Device In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| US 11,135,361 | Closed Tip Dynamic Microvalve Protection Device In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| US 9,770,319 | Closed Tip Dynamic Microvalve Protection Device In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| US 9,968,740 | Closed Tip Dynamic Microvalve Protection Device In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| US 12,138,424 | Closed Tip Dynamic Microvalve Protection Device In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| US 9,889,031 | Method of Gastric Artery Embolization In force · High confidence | Trisalus Life Sciences, Inc. | In force | High confidence | ||
| Application 19/429,621 | Closed Tip Dynamic Microvalve Protection Device Pending Not granted | TriSalus Life Sciences, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Trisalus Life Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.